Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells
出版年份 2014 全文链接
标题
Roflumilast N-Oxide Prevents Cytokine Secretion Induced by Cigarette Smoke Combined with LPS through JAK/STAT and ERK1/2 Inhibition in Airway Epithelial Cells
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 1, Pages e85243
出版商
Public Library of Science (PLoS)
发表日期
2014-01-09
DOI
10.1371/journal.pone.0085243
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro
- (2012) J Milara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reactive oxygen species mediate Jak2/Stat3 activation and IL-8 expression in pulmonary epithelial cells stimulated with lipid-associated membrane proteins from Mycoplasma pneumoniae
- (2012) Sang Yong Choi et al. INFLAMMATION RESEARCH
- Src tyrosine kinase inhibition prevents pulmonary ischemia–reperfusion-induced acute lung injury
- (2012) Takeshi Oyaizu et al. INTENSIVE CARE MEDICINE
- Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide
- (2011) A Buenestado et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhalation of LPS induces inflammatory airway responses mimicking characteristics of chronic obstructive pulmonary disease
- (2011) Magnus Korsgren et al. CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING
- PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease
- (2011) Zuzana Diamant et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- MAPK signaling pathways regulate IL-8 mRNA stability and IL-8 protein expression in cystic fibrosis lung epithelial cell lines
- (2010) Sharmistha Bhattacharyya et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Galactose specific adhesin of enteroaggregative E. coli induces IL-8 secretion via activation of MAPK and STAT-3 in INT-407 cells
- (2010) Atul Goyal et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Treatment of Chronic Obstructive Pulmonary Disease with Roflumilast, a New Phosphodiesterase 4 Inhibitor
- (2010) Nicholas J. Gross et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- A phosphodiesterase 4 inhibitor, roflumilast N-oxide, inhibits human lung fibroblast functions in vitro
- (2010) F. Sabatini et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
- (2010) Armin Hatzelmann et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- The Cytokine Network in Chronic Obstructive Pulmonary Disease
- (2009) Peter J. Barnes AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Direct effect of cigarette smoke on human pulmonary artery tension
- (2009) Jose Luis Ortiz et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Alveolar Cell Senescence Exacerbates Pulmonary Inflammation in Patients with Chronic Obstructive Pulmonary Disease
- (2009) Takao Tsuji et al. RESPIRATION
- Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells
- (2008) Elisabetta Pace et al. IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started